Quick Answer
HEALTHEQUITY, INC. reported Research And Development Expense of $262.51 million for the year ending 2026.
- HEALTHEQUITY, INC. showed an increase of +9.6% in Research And Development Expense from 2025 to 2026.
- This data is from HEALTHEQUITY, INC.'s annual report (Form 10-K), filed with the SEC on March 17, 2026.
- XBRL data for this metric is available from 2013 to 2026 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 14 years of available data (2013 to 2026), HEALTHEQUITY, INC.'s Research And Development Expense has grown by 6,107.4%.
- Historical annual values: Fiscal year 2026: $262.51 million | Fiscal year 2025: $239.51 million | Fiscal year 2024: $218.81 million | Fiscal year 2023: $193.38 million | Fiscal year 2022: $157.36 million | Fiscal year 2021: $124.81 million | Fiscal year 2020: $77.58 million | Fiscal year 2019: $35.06 million | Fiscal year 2018: $27.39 million | Fiscal year 2017: $22.38 million | Fiscal year 2016: $16.83 million | Fiscal year 2015: $10.50 million | Fiscal year 2014: $7.14 million | Fiscal year 2013: $4.23 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: